Low Klotho Levels Linked to Higher Sarcopenia Risk in Large US Study
A NHANES analysis of 1,250 adults finds that lower serum α-Klotho levels correlate with greater sarcopenia risk and reduced grip strength.
Summary
Researchers analyzed data from 1,250 NHANES participants (2011–2016) to explore whether the anti-aging protein α-Klotho is associated with sarcopenia — the age-related loss of muscle mass and strength. Participants in the lowest quartile of serum α-Klotho had a significantly elevated sarcopenia risk. Higher α-Klotho levels correlated with lower sarcopenia risk in unadjusted and partially adjusted models, though significance was lost after full adjustment for confounders like sex, BMI, vitamin D, and disease status. A negative correlation between α-Klotho and grip strength was observed across the full sample and in aging-related subgroups. The authors suggest measuring α-Klotho in clinical settings could help identify individuals at high risk for sarcopenia.
Detailed Summary
Sarcopenia — the progressive loss of skeletal muscle mass and strength — is a growing public health concern, especially as global populations age. It is associated with falls, disability, and increased mortality. Identifying reliable biomarkers that predict sarcopenia risk could transform early intervention strategies.
This cross-sectional study drew on NHANES data collected between 2011 and 2016, examining 1,250 adult participants. Researchers stratified participants into four quartiles based on serum α-Klotho levels and assessed sarcopenia using skeletal muscle index and handgrip strength. Multivariable logistic regression was used to test associations.
Key findings showed that individuals with sarcopenia had significantly lower serum α-Klotho compared to those without. In unadjusted and partially adjusted models, higher α-Klotho was associated with reduced sarcopenia risk. However, this association did not reach statistical significance in the fully adjusted model, which accounted for sex, ethnicity, BMI, alcohol use, vitamin D levels, and disease status. A negative correlation between α-Klotho levels and grip strength persisted across the overall sample and the aging subgroup.
The results suggest that α-Klotho may play a role in muscle health maintenance, possibly through its established involvement in vitamin D and phosphate metabolism — both pathways relevant to musculoskeletal function. The relationship appears especially noteworthy in the context of renal disease, where Klotho deficiency is common and sarcopenia prevalence is high.
Important caveats apply: the cross-sectional design prevents causal conclusions, full adjustment attenuated statistical significance, and the study relied on a single measurement of Klotho. Nevertheless, the findings support α-Klotho as a candidate clinical biomarker for sarcopenia risk stratification, warranting longitudinal and mechanistic follow-up.
Key Findings
- Participants in the lowest α-Klotho quartile had significantly elevated sarcopenia risk compared to higher quartiles.
- Higher α-Klotho correlated with lower sarcopenia risk in unadjusted and partially adjusted models.
- Full covariate adjustment (sex, BMI, vitamin D, disease) attenuated the association to non-significance.
- A negative correlation between α-Klotho levels and grip strength was observed across all age groups studied.
- Authors propose serum α-Klotho measurement as a potential clinical screening tool for sarcopenia risk.
Methodology
Cross-sectional analysis of 1,250 NHANES participants (2011–2016) stratified by serum α-Klotho quartiles. Sarcopenia was defined using skeletal muscle index and handgrip strength. Multivariable logistic regression models were applied with progressive covariate adjustment.
Study Limitations
The cross-sectional design prevents establishing causality between α-Klotho and sarcopenia. The association lost statistical significance after full covariate adjustment, indicating confounding plays a substantial role. Single time-point Klotho measurements may not reflect chronic exposure or biological variability.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: